diclofenac epolamine
- Product NDC
- 0093-3225
- 11-digit product format
- 000933225
- Labeler code
- 0093
- Product ID
- 0093-3225_a21c54f0-fd5c-44f5-9388-bd98d9f2e1b1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diclofenac Epolamine
- Dosage form
- PATCH
- Route
- TOPICAL
- Labeler
- Teva Pharmaceuticals USA Inc.
- Application
- NDA021234
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2019-03-01
- Marketing end
- 2022-10-31
- Substance
- DICLOFENAC EPOLAMINE
- Active strength
- 0 g/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-3225-55 | 00093322555 | 6 POUCH in 1 CARTON (0093-3225-55) > 5 PATCH in 1 POUCH (0093-3225-50) | 6 pouch | 2019-03-01 | 2022-10-31 | No | No | Current |